Literature DB >> 11039578

A refined physical and transcriptional map of the SPG9 locus on 10q23.3-q24.2.

C Lo Nigro1, R Cusano, M Scaranari, R Cinti, P Forabosco, V B Morra, G De Michele, L Santoro, S Davies, J Hurst, M Devoto, R Ravazzolo, M Seri.   

Abstract

Hereditary spastic paraplegia (HSP) is a genetically heterogeneous disorder characterised by progressive spasticity of the lower limbs. Beside 'pure' forms of HSP, 'complicated' forms are reported, where spasticity occurs associated with additional symptoms. We recently described an Italian family with a complicated dominant form of HSP (SPG9) and we mapped the gene responsible to 10q23.3-q24.2, in a 12cM interval between markers D10S564 and D10S603. The phenotypic manifestations in our family are reminiscent of those already described in a smaller British pedigree. We typed individuals from this British family using markers located in the SPG9 critical interval and haplotype reconstruction showed the disorder co-segregating with SPG9. To characterise the SPG9 region better, we constructed a contig of 22 YACs, assigned it to 18 polymorphic markers and positioned 54 ESTs. Furthermore, we searched for ESTs containing a trinucleotide repeat sequence, since anticipation of symptoms was reported in both families. Finally, analysis of a muscle biopsy specimen from one patient was normal, suggesting that, contrary to SPG7, mitochondrial disturbance could not be a primary feature of SPG9.

Entities:  

Mesh:

Year:  2000        PMID: 11039578     DOI: 10.1038/sj.ejhg.5200546

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  2 in total

1.  ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia.

Authors:  Ashraf U Mannan; Philip Krawen; Simone M Sauter; Johann Boehm; Agnieszka Chronowska; Walter Paulus; Juergen Neesen; Wolfgang Engel
Journal:  Am J Hum Genet       Date:  2006-06-01       Impact factor: 11.025

2.  Refined physical map of the human PAX2/HOX11/NFKB2 cancer gene region at 10q24 and relocalization of the HPV6AI1 viral integration site to 14q13.3-q21.1.

Authors:  Sheryl M Gough; Margaret McDonald; Xiao-Ning Chen; Julie R Korenberg; Antonino Neri; Tomas Kahn; Michael R Eccles; Christine M Morris
Journal:  BMC Genomics       Date:  2003-03-03       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.